GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Smith & Nephew PLC (CHIX:SNl) » Definitions » Institutional Ownership

Smith & Nephew (CHIX:SNL) Institutional Ownership : 59.61% (As of Jun. 17, 2025)


View and export this data going back to 2009. Start your Free Trial

What is Smith & Nephew Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Smith & Nephew's institutional ownership is 59.61%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Smith & Nephew's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Smith & Nephew's Float Percentage Of Total Shares Outstanding is 0.00%.


Smith & Nephew Institutional Ownership Historical Data

The historical data trend for Smith & Nephew's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smith & Nephew Institutional Ownership Chart

Smith & Nephew Historical Data

The historical data trend for Smith & Nephew can be seen below:

2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31 2025-04-30 2025-05-31
Institutional Ownership 58.54 58.32 59.26 59.39 60.71 60.35 60.13 59.54 59.96 59.61

Smith & Nephew Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Smith & Nephew Business Description

Traded in Other Exchanges
Address
Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew Headlines

No Headlines